CONNECT WITH US
Funding Tracker

Funding Tracker

IIT-BHU alumnus Anuruddh Mishra's August AI raises $12 million to take on US healthcare paperwork

Indian Startup News – Funding logo

Published on

Add as a preferred source on Google
IIT-BHU alumnus Anuruddh Mishra's August AI raises $12 million to take on US healthcare paperwork

AI healthtech startup August AI has raised $12 million from Accel and Peak XV Partners, and has launched an AI agent that makes phone calls to doctors, pharmacies and insurers on behalf of patients in the US.

In a post on X, August AI founder and CEO Anuruddh Mishra shared details of the funding alongside the rollout of new capabilities. He said the funds would be used to deploy AI to address the challenges patients face while navigating the US healthcare system.

We raised $12M from @Accel and @PeakXV to put AI through the bullshit American healthcare puts you through.

Navigating healthcare is hard and all of us have a list of healthcare tasks we’ve been putting off. From visiting a doctor to filing an insurance claim, the tasks pile up… pic.twitter.com/agNKSPoUwG

The startup said it has raised a total of $12 million to date from Peak XV Partners and Accel. It did not disclose its valuation or identify a lead investor.

August AI raised $3 million in a seed round in October 2025 from Accel and Claypond Capital, the family office of Manipal Group chairman Ranjan Pai. 

Founded in 2022 by IIT-BHU alumnus Mishra, August AI started as an AI health companion that helps users understand symptoms, prescriptions, medications and medical reports. It also offers nutrition guidance, medication reminders and personalised health insights, through its app, website and WhatsApp.

5 million people in 160 countries, in over 30 languages. When it raised its seed round in October 2025, it claimed over 35 lakh active users, including 1 lakh doctors.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.